International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.

A Study on the Comparison of Dexmedetomidine as an Adjuvant to Intrathecal Bupivacaine Versus Bupivacaine Alone in Lower Abdominal & Lower Limb Surgeries

Author(s) Mr. Syed Imran Hussain, Dr. Abhishek Gupta, Mr. Ishfaq Ramzan, Dr. Hilal Ahmed
Country India
Abstract Background Spinal anaesthesia is a widely practised regional anaesthetic technique for lower abdominal and lower limb surgeries. The use of intrathecal adjuvants has been explored to enhance the quality and duration of spinal anaesthesia. Dexmedetomidine, a highly selective alpha-2 adrenergic agonist, has gained attention as an effective intrathecal adjuvant because of its analgesic, sedative, and sympatholytic properties
Methods: A total of 60 patients aged between 20–60 years, belonging to ASA physical status I and II, undergoing lower limb surgeries and caesarean section under spinal anaesthesia were included in the study. The patients were randomly divided into two groups. Group A (n=30): Received 3 ml of 0.5% hyperbaric bupivacaine intrathecally. Group B (n=30): Received 3 ml of 0.5% hyperbaric bupivacaine with 5 μg dexmedetomidine intrathecally.
Results: The addition of dexmedetomidine to intrathecal bupivacaine resulted in faster onset of sensory block. Hemodynamic parameters remained stable in both groups, and adverse effects were minimal and manageable.
Conclusion: Dexmedetomidine prolongs the duration of spinal anaesthesia and provides better postoperative analgesia without significant side effects.
Keywords KEYWORDS: Spinal anaesthesia, Bupivacaine, Dexmedetomidine.
Field Medical / Pharmacy
Published In Volume 8, Issue 2, March-April 2026
Published On 2026-04-09

Share this